CD8A and neoplasm: Immunoscore is based on the quantification of CD3+ and CD8+ TILs in the tumor core and the invasive margin of resected tumors and uses this numeration of TILs to provide a score ranging from Immunoscore 0, when low numbers of both cell types are described in both regions, to Immunoscore 4, when high numbers are described in both regions.